Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-08 3:17 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | JANUS HENDERSON GROUP PLC JHG | 6,414,642 6.1% | 6,414,642 (New Position) | View |
2024-03-05 5:42 pm Purchase | 13D | APPLIED THERAPEUTICS INC APLT | Shendelman Shoshana | 8,646,891 8.2% | 565,946 (+7.00%) | View |
2024-02-22 2:26 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | Propel Bio Management LLC | 8,071,526 10.5% | 3,314,144 (+69.66%) | View |
2024-02-14 9:20 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | Venrock Healthcare Capital Partners III L.P. | 7,877,817 9.99% | 2,080,232 (+35.88%) | View |
2024-02-14 6:30 pm Sale | 13G | APPLIED THERAPEUTICS INC APLT | ORBIMED ADVISORS LLC | 0 0% | -7,300,921 (Position Closed) | View |
2024-02-14 4:52 pm Unchanged | 13G | APPLIED THERAPEUTICS INC APLT | PERCEPTIVE ADVISORS LLC | 4,580,249 5.9% | 0 (Unchanged) | View |
2024-02-14 4:22 pm Sale | 13G | APPLIED THERAPEUTICS INC APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. ARE | 12,859,054 15.4% | -575,000 (-4.28%) | View |
2024-02-14 2:40 pm Sale | 13G | APPLIED THERAPEUTICS INC APLT | ARMISTICE CAPITAL LLC | 0 0% | -5,333,951 (Position Closed) | View |
2024-02-14 1:50 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | Alyeska Investment Group L.P. | 7,715,197 9.99% | 2,910,197 (+60.57%) | View |
2024-02-13 4:34 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | Vestal Point Capital LP | 4,155,000 5.4% | 4,155,000 (New Position) | View |
2024-02-09 08:35 am Sale | 13G | APPLIED THERAPEUTICS INC APLT | FMR LLC | 2,427,436 3.143% | -544,935 (-18.33%) | View |
2024-02-06 08:49 am Sale | 13G | APPLIED THERAPEUTICS INC APLT | FRANKLIN RESOURCES INC BEN | 7,793,912 9.99% | -76,785 (-0.98%) | View |
2023-12-11 12:29 pm Sale | 13G | APPLIED THERAPEUTICS INC APLT | FRANKLIN RESOURCES INC BEN | 7,870,697 10.2% | -76,035 (-0.96%) | View |
2023-12-06 4:15 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | PERCEPTIVE ADVISORS LLC | 4,580,249 5.9% | 4,580,249 (New Position) | View |
2023-11-13 5:10 pm Purchase | 13D | APPLIED THERAPEUTICS INC APLT | Shendelman Shoshana | 8,080,945 10.1% | 5,568 (+0.07%) | View |
2023-05-10 12:03 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | FRANKLIN RESOURCES INC BEN | 7,946,732 16.5% | 3,171,248 (+66.41%) | View |
2023-05-08 4:05 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | Venrock Healthcare Capital Partners III L.P. | 5,797,585 9.99% | 5,797,585 (New Position) | View |
2023-05-02 1:24 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | Propel Bio Management LLC | 4,757,382 9.9% | 4,757,382 (New Position) | View |
2023-04-28 4:30 pm Purchase | 13D | APPLIED THERAPEUTICS INC APLT | Shendelman Shoshana | 8,075,377 13.3% | 504,542 (+6.66%) | View |
2023-03-30 5:35 pm Sale | 13G | APPLIED THERAPEUTICS INC APLT | Propel Bio Partners L.P. | 1,234,519 2.57% | -1,270,862 (-50.73%) | View |